Axogen (AXGN) Current Deferred Tax Assets (2010 - 2011)

Axogen (AXGN) recorded quarterly Current Deferred Tax Assets of $18000.0 in Q2 2011, down 96.65% quarter-over-quarter from $538000.0 in Q4 2010.

Axogen (AXGN) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends

Axogen's Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at $18000.0 for Q2 2011.

In Q2 2011, Current Deferred Tax Assets changed N/A year-over-year to $18000.0; the TTM figure through Jun 2011 stood at $18000.0 (changed N/A YoY), while the FY2010 annual figure was $538000.0, changed N/A from the prior year.
Current Deferred Tax Assets was $18000.0 for Q2 2011 at Axogen, down from $538000.0 in the prior quarter.
In the past five years, Current Deferred Tax Assets ranged from a high of $538000.0 in Q4 2010 to a low of $18000.0 in Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Axogen	2.32 Bn	2.22 Bn	46.19 Mn

Download Data